T-cell-targeted peptide epitope vaccine (hand-foot-and-mouth disease) (Emergex/IMCB)

N/A

Report date: 2025/01/26 16:40:58

Base Information

Drug NameT-cell-targeted peptide epitope vaccine (hand-foot-and-mouth disease) (Emergex/IMCB)
Drug Alias NameT-cell-targeted peptide epitope vaccine (hand-foot-and-mouth disease) (Emergex/Institute of Molecular and Cell Biology)
ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsEnterovirus 71 infectionCoxsackievirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGylden Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Molecular And Cell BiologyGylden Pharma Ltd
Inactive CompaniesN/A
Active IndicationsEnterovirus 71 infectionCoxsackievirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A